Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

Abstract Background Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study aimed to identify factors physicians and nurses considered regarding adj...

Full description

Bibliographic Details
Main Authors: Ann Livingstone, Kathy Dempsey, Martin R. Stockler, Kirsten Howard, Georgina V. Long, Matteo S. Carlino, Alexander M. Menzies, Rachael L. Morton
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
Melanoma
Immunotherapy
Interviews
Physicians
Surgeons
Nurse clinicians
Online Access:https://doi.org/10.1186/s12885-021-08752-1

Internet

https://doi.org/10.1186/s12885-021-08752-1

Similar Items